Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$718 Hold
2
– – ﹤0.01% 2516
2026
Q2
$631 Hold
2
– – ﹤0.01% 2624
2026
Q1
$687 Buy
+2
New +$713 ﹤0.01% 2609
2025
Q4
– Sell
-3,056
Closed -$969K – 2794
2025
Q3
$862K Sell
3,056
-11,329
-79% -$3.29M ﹤0.01% 1904
2025
Q2
$4.02M Buy
14,385
+14,383
+719,150% +$4.07M 0.01% 1070
2025
Q1
$629 Buy
+2
New +$591 ﹤0.01% 2894
2024
Q4
– Sell
-2
Closed -$593 – 3081
2024
Q3
$502 Buy
+2
New +$654 ﹤0.01% 3396
2024
Q2
– Sell
-2
Closed -$588 – 3505
2024
Q1
$708 Hold
2
– – ﹤0.01% 3877
2023
Q4
$512 Buy
+2
New +$545 ﹤0.01% 4125
2023
Q2
– Sell
-2
Closed -$464 – 3887
2023
Q1
$541 Buy
+2
New +$491 ﹤0.01% 4146
2022
Q2
– Sell
-3
Closed -$735 – 3896
2022
Q1
$1K Hold
3
– – ﹤0.01% 4985
2021
Q4
$1K Sell
3
-14,063
-100% -$2.97M ﹤0.01% 5007
2021
Q3
$2.99M Buy
14,066
+14,061
+281,220% +$3.24M 0.01% 1574
2021
Q2
$1K Buy
+5
New +$1.23K ﹤0.01% 4922
2019
Q2
– Sell
-8,669
Closed -$1.55M – 3602
2019
Q1
$1.65M Buy
+8,669
New +$1.66M 0.01% 1443

Other funds holding AMGN

PEAK6's AMGN Position: Q3 2026 in Review

PEAK6 held its Amgen (AMGN) position steady in Q3 2026 at 2 shares worth $718. The position accounts for ﹤0.01% of the portfolio, ranked #2516.

PEAK6 first reported a position in AMGN in Q1 2019 and has held it in 15 quarters since. The position peaked at $4.02M in Q2 2025. 3,275 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • PEAK6 held 2 shares of Amgen worth $718 as of Q3 2026.
  • PEAK6 left its Amgen share count unchanged in Q3 2026.
  • Amgen made up ﹤0.01% of PEAK6's portfolio in Q3 2026, its #2516 holding.
  • PEAK6 first reported a position in Amgen in Q1 2019 and has held it in 15 quarters since.
  • PEAK6's Amgen position peaked at $4.02M in Q2 2025.
  • 3,275 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on PEAK6's 13F filing for Q3 2026, filed 13 Nov 2026.